Round Type
Series B
Menlo ParkBiotechnologyHealthcareHealth CareInvestors
Description
ReCode Therapeutics, a clinical-stage genetic medicines company using precision delivery to power the next wave of mRNA and gene correction therapeutics, today announced the closing of an extension to its Series B financing, raising an additional $50 million, and the appointment of Kouki Harasaki, Ph.D., founding and managing partner of Bioluminescence Ventures (BLV), to the company’s board of directors.
Quick answer
ReCode Therapeutics raised an undisclosed amount in a Series B round, dated September 19, 2023. Investors: Bioluminescence Ventures. ReCode Therapeutics is based in Menlo Park, California, United States.
- How much did ReCode Therapeutics raise?
- ReCode Therapeutics raised an undisclosed amount in a Series B round on September 19, 2023.
- Who invested in ReCode Therapeutics?
- Bioluminescence Ventures is named as investors in this round.
- What does ReCode Therapeutics do?
- ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.
- Where is ReCode Therapeutics based and how big is it?
- ReCode Therapeutics is based in Menlo Park, California, United States.
- Who are the decision-makers at ReCode Therapeutics?
- Fundz holds 1 contact at ReCode Therapeutics, including the Head of Clinical Operations | Rare Diseases. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as ReCode Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Greenbrook TMS raised $2M (Seed) on November 2, 2023.
- Yarrow Bioscience raised $88M on November 1, 2023.
- Gyre Therapeutics raised $5M on October 30, 2023.
- Pharmazz raised $450K (Seed) on October 24, 2023.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
- Azora Therapeutics, Inc. (DE) raised $4M (Seed) on October 19, 2023.
Who to call at ReCode Therapeutics, and when
A new round usually means ReCode Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ReCode Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ReCode Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ReCode Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ReCode Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansReCode Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.